Furthermore, in vitro and in vivo mouse experiments from 2023 show that the NOTCH-RIPK4-IRF6-ELOVL4 signaling axis acts as a potent tumor suppressor in squamous cell carcinomas [26]. This evidence concerns the gene ELOVL4 and squamous cell carcinoma.